Breathe Well Live Well
|
Clinical trials start for ABI's breath asthma check rapid assay
Stock Market Wire StockMarketWire.com – Clinical trials for Akers Biosciences' breath asthma check rapid assay have begun in Clearwater, Florida. The trials have been designed to provide the clinical information to be included in a submission for regulatory approvals … 18 APRIL 2011 Akers Biosciences* AKR (FTSE AIM All Share) 4p BUY (TP-10p) |
View full post on asthma – Google News
|
Skyepharma banking on European approval for Flutiform
Stock Market Wire The group said it was counting on European approval of asthma treatment Flutiform and launch in the second half of 2011. Revenue was up 4% to £58.1m from £55.9m, in line with management expectations. The rise was primarily due to a substantial increase … SkyePharma Moves To 2010 Pretax Profit, Sees Cash Outflows STOCKS NEWS UK-SkyePharma up on results Flutiform optimism Skyepharma turns in annual profit |
View full post on asthma – Google News
|
Fitness First Launches Asthma UK Fundraising With Balloons Over Dorset
Stock Markets Review (press release) Fitness First marked its new fundraising partnership with Asthma UK (Friday November 19) by releasing 100 green helium filled balloons from Fitness First''s … Asthma UK and Fitness First |
View full post on asthma – Google News
|
Medco Health Solutions (NYSE:MHS) Says Asthma Is Overmedicated
Stock Briefings Medco Health Solutions (NYSE:MHS) has said that patients are using too many drugs for mild-asthma. Medco Health Solutions (NYSE:MHS) shares were at 61 at … |
View full post on asthma – Google News
|
Palatin Tech To Cut Work Force In Half, Do Reverse Stock Split
Wall Street Journal Palatin has been developing bremelanotide for male and female sexual dysfunction and PL-3994 for acute severe asthma. The company plans to submit plans for … Palatin Announces Strategic Realignment of Operations Palatin Reducing Workforce By 50%; To Effect 1-for-10 Reverse Stock Split … |
View full post on asthma – Google News
|
Pharmaceutical Stock Watch – Why TEVA is One to Watch
Beacon Equity Research (blog) The benefit offered though QVAR was the lower dose at witch asthma control was achieved. The results were published in the September issue of the Journal of … QVAR(R) Versus Fluticasone in a Real-World Study Highlights the Importance of … |
View full post on asthma – Google News